共 33 条
[1]
Beavo J.A., Conti M., Heaslip R.J., Multiple cyclic nucleotide phosphodiesterases, Mol. Pharmacol., 46, pp. 399-405, (1994)
[2]
Conti M., Jin S.C., Monaco L., Repaske D.R., Swinnen J.V., Hormonal regulation of cyclic nucleotide phosphodiesterases, Endocrin. Rev., 12, pp. 218-234, (1991)
[3]
Beavo J.A., Reifsnyder D.H., Primary sequences of phosphodiesterase isoenzymes and design of selective inhibitors, Trends Pharmacol., 11, pp. 150-155, (1990)
[4]
Thompson W.J., Cyclic nucleotide phosphodiesterases: Pharmacology, biochemistry and function, Pharmacol. Ther., 57, pp. 13-33, (1991)
[5]
Manganiello V.C., Murata T., Degerman E., Belfrage P., Diversity in cyclic nucleotide phosphodiesterase isoenzyme families, Arch. Biochem. Biophys., 322, pp. 1-13, (1995)
[6]
Degerman E., Belfrage P., Manganiello V.C., Structure, localization and regulation of cGMP-inhibited phosphodiesterase (PDE3), J. Biol Chem., 272, pp. 6823-6826, (1997)
[7]
Charbonneau H., Structure-function relationships among cyclic nucleotide phosphodiesterases, Cyclic Nucleotide Phosphodiesterases: Structure, Regulation, and Drug Action, pp. 267-296, (1990)
[8]
Meacci E., Taira M., Moos Jr. M., Smith C.J., Movsesian M.A., Degerman E., Belfrage P., Manganiello V.C., Molecular cloning and expression of human myocardial cGMP-inhibited cAMP phosphodiesterase, Proc. Natl. Acad. Sci. USA, 89, pp. 3721-3725, (1992)
[9]
Pillai R., Staub S.F., Colicelli J., Mutational mapping of kinetic and pharmacological properties of a human cardiac cAMP phosphodiesterase, J. Biol. Chem., 269, pp. 30676-30682, (1994)
[10]
Jin S.L., Swinnen J.V., Conti M., Characterization of the structure of a low K<sub>m</sub>, rolipram- Sensitive cAMP phosphodiesterase: Mapping of the catalytic domain, J. Biol. Chem., 267, pp. 18929-18939, (1992)